Literature DB >> 19371473

Strategies for repeat prostate biopsies.

Martha K Terris1.   

Abstract

Urologists are routinely faced with the dilemma of a persistently worrisome clinical picture for prostate cancer in patients who have undergone prior negative ultrasound-guided prostate biopsies. Indications for repeat biopsy include sustained or worsening of the findings that prompted the initial biopsy; various derivations of prostate-specific antigen; and the histology from the initial biopsy (ie, high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation is identified). Large prostate volume or inflammation can confound the decision to perform repeat biopsies. Repeat biopsies should include a combination of standard sextant, lateral, anterior apical, and possibly transition zone biopsies. Repeat biopsies should consist of at least 14 cores but may include more than 36 samples. In patients who are not at high risk for prostate cancer, more than two sets of repeat biopsies have a very low yield.

Entities:  

Mesh:

Year:  2009        PMID: 19371473     DOI: 10.1007/s11934-009-0030-y

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  50 in total

1.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Authors:  W J Catalona; A W Partin; K M Slawin; M K Brawer; R C Flanigan; A Patel; J P Richie; J B deKernion; P C Walsh; P T Scardino; P H Lange; E N Subong; R E Parson; G H Gasior; K G Loveland; P C Southwick
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

2.  Critical evaluation of the current indications for transition zone biopsies.

Authors:  I J Liu; M Macy; Y H Lai; M K Terris
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

3.  Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study.

Authors:  Bob Djavan; Yan Kit Fong; Vincent Ravery; Mesut Remzi; Wolfgang Horninger; Martin Susani; Soren Kreuzer; Laurent Boccon-Gibod; Georg Bartsch; Michael Marberger
Journal:  Eur Urol       Date:  2005-01       Impact factor: 20.096

4.  Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.

Authors:  J Stephen Jones; Amit Patel; Lynn Schoenfield; John C Rabets; Craig D Zippe; Cristina Magi-Galluzzi
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

5.  High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates.

Authors:  Kamran P Sajadi; Timothy Kim; Martha K Terris; James A Brown; Ronald W Lewis
Journal:  Urology       Date:  2007-10       Impact factor: 2.649

6.  Reassessing the diagnostic yield of saturation biopsy of the prostate.

Authors:  Richard A Ashley; Brant A Inman; Jonathan C Routh; Lance A Mynderse; Matthew T Gettman; Michael L Blute
Journal:  Eur Urol       Date:  2007-11-05       Impact factor: 20.096

Review 7.  Prostate biopsy strategies.

Authors:  Joseph C Presti
Journal:  Nat Clin Pract Urol       Date:  2007-09

8.  Transrectal ultrasound imaging and ultrasound guided prostate biopsies in the detection of residual carcinoma in clinical stage A carcinoma of the prostate.

Authors:  M K Terris; J E McNeal; T A Stamey
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

9.  Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies.

Authors:  Y Mark Hong; Frank C Lai; Chris H Chon; John E McNeal; Joseph C Presti
Journal:  Urol Oncol       Date:  2004 Jan-Feb       Impact factor: 3.498

10.  Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies.

Authors:  Robert Abouassaly; Nelly Tan; Ayman Moussa; J Stephen Jones
Journal:  J Urol       Date:  2008-07-17       Impact factor: 7.450

View more
  9 in total

1.  An MRI-compatible robotic system with hybrid tracking for MRI-guided prostate intervention.

Authors:  Axel Krieger; Iulian I Iordachita; Peter Guion; Anurag K Singh; Aradhana Kaushal; Cynthia Ménard; Peter A Pinto; Kevin Camphausen; Gabor Fichtinger; Louis L Whitcomb
Journal:  IEEE Trans Biomed Eng       Date:  2011-11       Impact factor: 4.538

2.  The nomogram conundrum: a demonstration of why a prostate cancer risk model in Turkish men underestimates prostate cancer risk in the USA.

Authors:  Onder Kara; Ahmed Elshafei; Yaw A Nyame; Bulent Akdogan; Ercan Malkoc; Tianming Gao; Mesut Altan; Burak Citamak; Emin Mammadov; Furkan Dursun; Daniel J Greene; Temucin Senkul; Ferhat Ates; Haluk Ozen; J Stephen Jones
Journal:  Int Urol Nephrol       Date:  2016-05-28       Impact factor: 2.370

3.  Methylation in benign prostate and risk of disease progression in men subsequently diagnosed with prostate cancer.

Authors:  Benjamin A Rybicki; Andrew Rundle; Oleksandr N Kryvenko; Nicoleta Mitrache; Kieu C Do; Michelle Jankowski; Dhananjay A Chitale; Sheri Trudeau; Steven A Belinsky; Deliang Tang
Journal:  Int J Cancer       Date:  2016-03-02       Impact factor: 7.396

4.  Is sampling transitional zone in patients who had prior negative prostate biopsy necessary?

Authors:  Bayram Dogan; Ege Can Serefoglu; Ali Fuat Atmaca; Abdullah Erdem Canda; Ziya Akbulut; M Derya Balbay
Journal:  Int Urol Nephrol       Date:  2012-03-15       Impact factor: 2.370

5.  Biopsy needle artifact localization in MRI-guided robotic transrectal prostate intervention.

Authors:  Sang-Eun Song; Nathan Bongjoon Cho; Iulian I Iordachita; Peter Guion; Gabor Fichtinger; Aradhana Kaushal; Kevin Camphausen; Louis L Whitcomb
Journal:  IEEE Trans Biomed Eng       Date:  2012-04-03       Impact factor: 4.538

6.  Development and Evaluation of an Actuated MRI-Compatible Robotic System for MRI-Guided Prostate Intervention.

Authors:  Axel Krieger; Sang-Eun Song; Nathan B Cho; Iulian Iordachita; Peter Guion; Gabor Fichtinger; Louis L Whitcomb
Journal:  IEEE ASME Trans Mechatron       Date:  2011-10-17       Impact factor: 5.303

7.  Accuracy analysis in MRI-guided robotic prostate biopsy.

Authors:  Helen Xu; Andras Lasso; Peter Guion; Axel Krieger; Aradhana Kaushal; Anurag K Singh; Peter A Pinto; Jonathan Coleman; Robert L Grubb; Jean-Baptiste Lattouf; Cynthia Menard; Louis L Whitcomb; Gabor Fichtinger
Journal:  Int J Comput Assist Radiol Surg       Date:  2013-03-27       Impact factor: 2.924

8.  Multi-slice-to-volume registration for MRI-guided transperineal prostate biopsy.

Authors:  Helen Xu; Andras Lasso; Andriy Fedorov; Kemal Tuncali; Clare Tempany; Gabor Fichtinger
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-09-06       Impact factor: 2.924

9.  Transrectal ultrasound-guided prostate rebiopsy: How many core sampling should be applied to which patient?

Authors:  Akın Soner Amasyalı; Uğur Yücetaş; Erkan Erkan; Murat Demiray; Emre Karabay; Cemalettin Murat; Gökhan Toktaş; Erdinç Ünlüer
Journal:  Urol Ann       Date:  2018 Jan-Mar
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.